The fresh tissues were obtained from 64 colorectal adenocarcinoma (43 well-differentiated and moderately-differentiated adenocarcinoma, 12 poorly- differentiated adenocarcinoma and 9 mutinous cell carcinoma including ...The fresh tissues were obtained from 64 colorectal adenocarcinoma (43 well-differentiated and moderately-differentiated adenocarcinoma, 12 poorly- differentiated adenocarcinoma and 9 mutinous cell carcinoma including signet ring cell carcinoma) during surgical operation. The resected edge of each specimen was used for control group. The arylsulfatase B was studied by histochentical staining in different types of colorectal adenocarcinoma, among which 19 cases were investigated by electronhistochemical staining so as to observe the Ruthenium Red granules alteration which represented the extracellular proteoglycan changes and ultrastructure of cancer cells.The results showed that the mutinous cell carcinoma was of the most Intensive arylsulfatase B activity and has a lot of secretory granules with various electron densities in the cytoplasm. The Ruthenium Red granules close to the cancer cell disappeared, a part of remainders changed into the lowered electron density and indistinct shape. In contrast, the other types adenocarcinoma revealed less enzyme activity and a fewer secretory granules. The Ruthenium Red granules near the cancer nest showed that their electron density and size were identical with those of the control group. All of these mentioned above indicate that mucinouscell carcinoma may release hydrolase into pericancerous matrix to degrade the proteoglycans. In view of the network structure formed by proteoglycan in the connective tissue, network has ability to hinder the cancer cell spreading. Because the arylsulfatase B is able to degrade the dermatan sulfate proteoglycan which is component of proteoglycans in the extracellular matrix of human colon. We consider that the arylsulfatase B may lead to destruction of the network barriers in the connective tissue in favour of cancer cell invasion. So the mucinous cell carcinoma is more malignant than those of other colorectal adenocarcinoma.展开更多
目的分析1例晚期婴儿型异染性脑白质营养不良病(metachromatic leukodystrophy,MLD)患儿芳基硫酸酯酶A(arylsulfatase A,ARSA)编码基因的变异情况。方法应用Sanger测序方法检测ARSA基因第1~8共8个外显子序列。用PubMed Protein BLAST分...目的分析1例晚期婴儿型异染性脑白质营养不良病(metachromatic leukodystrophy,MLD)患儿芳基硫酸酯酶A(arylsulfatase A,ARSA)编码基因的变异情况。方法应用Sanger测序方法检测ARSA基因第1~8共8个外显子序列。用PubMed Protein BLAST分析ARSA的跨种属保守性;应用Ucsf chimera软件对正常结构及变异结构的ARSA进行蛋白质3D结构建模及比对来分析变异所致的蛋白二级结构的丧失及蛋白空间结构的改变;应用PolyPhen-2、Mutation Taster及SIFT软件对新变异进行功能预测。结果患儿携带ARSA基因第3外显子c.467G>A(p.Gly156Asp)和第5外显子c.960G>A(p.Trp320*)复合杂合变异。c.467G>A(p.Gly156Asp)变异经PolyPhen-2、Mutation Taster、SIFT及PROVEAN预测软件预测为可能有害变异,同时经PubMed Protein BLAST分析ARSA第156位Gly在各种属间均高度保守,该氨基酸改变可导致编码的ARSA功能发生障碍;c.960G>A(p.Trp320*)变异经Ucsf chimera软件进行蛋白3D结构建模分析发现,该变异可导致编码蛋白空间结构严重变形,原有功能丧失。结论ARSA基因c.467G>A(p.Gly156Asp)和c.960G>A(p.Trp320*)复合杂合变异可能为该患儿罹患MLD的致病原因,基因变异检测结果可以为家系的遗传咨询和产前诊断提供依据。展开更多
文摘The fresh tissues were obtained from 64 colorectal adenocarcinoma (43 well-differentiated and moderately-differentiated adenocarcinoma, 12 poorly- differentiated adenocarcinoma and 9 mutinous cell carcinoma including signet ring cell carcinoma) during surgical operation. The resected edge of each specimen was used for control group. The arylsulfatase B was studied by histochentical staining in different types of colorectal adenocarcinoma, among which 19 cases were investigated by electronhistochemical staining so as to observe the Ruthenium Red granules alteration which represented the extracellular proteoglycan changes and ultrastructure of cancer cells.The results showed that the mutinous cell carcinoma was of the most Intensive arylsulfatase B activity and has a lot of secretory granules with various electron densities in the cytoplasm. The Ruthenium Red granules close to the cancer cell disappeared, a part of remainders changed into the lowered electron density and indistinct shape. In contrast, the other types adenocarcinoma revealed less enzyme activity and a fewer secretory granules. The Ruthenium Red granules near the cancer nest showed that their electron density and size were identical with those of the control group. All of these mentioned above indicate that mucinouscell carcinoma may release hydrolase into pericancerous matrix to degrade the proteoglycans. In view of the network structure formed by proteoglycan in the connective tissue, network has ability to hinder the cancer cell spreading. Because the arylsulfatase B is able to degrade the dermatan sulfate proteoglycan which is component of proteoglycans in the extracellular matrix of human colon. We consider that the arylsulfatase B may lead to destruction of the network barriers in the connective tissue in favour of cancer cell invasion. So the mucinous cell carcinoma is more malignant than those of other colorectal adenocarcinoma.
